HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fuzheng Guo Selected Research

aspartoacylase

11/2021Ablating the Transporter Sodium-Dependent Dicarboxylate Transporter 3 Prevents Leukodystrophy in Canavan Disease Mice.
1/2020Antisense Oligonucleotide Reverses Leukodystrophy in Canavan Disease Mice.
1/2018Brain Nat8l Knockdown Suppresses Spongiform Leukodystrophy in an Aspartoacylase-Deficient Canavan Disease Mouse Model.
11/2017Suppressing N-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy.
5/2015Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fuzheng Guo Research Topics

Disease

6Multiple Sclerosis
01/2022 - 08/2011
5Canavan Disease (Leukodystrophy, Spongiform)
11/2021 - 05/2015
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2014 - 08/2011
4Demyelinating Diseases (Demyelinating Disease)
01/2021 - 01/2012
2Ataxia (Dyssynergia)
11/2021 - 01/2020
2COVID-19
01/2021 - 10/2020
2Atrophy
01/2020 - 11/2017
2Central Nervous System Diseases (CNS Diseases)
01/2012 - 08/2011
1Confusion (Bewilderment)
03/2021
1Inflammation (Inflammations)
01/2021
1Thrombosis (Thrombus)
01/2020
1Hypoxia (Hypoxemia)
01/2020
1Fetal Diseases (Embryopathy)
01/2019
1Gliosis
10/2013
1Carcinoma (Carcinomatosis)
06/2004
1Neoplasms (Cancer)
01/2004
1Lung Neoplasms (Lung Cancer)
01/2004

Drug/Important Bio-Agent (IBA)

5aspartoacylaseIBA
11/2021 - 05/2015
5Peptides (Polypeptides)IBA
06/2014 - 08/2011
5Myelin-Oligodendrocyte GlycoproteinIBA
06/2014 - 08/2011
4N-acetylaspartate (N-acetyl aspartate)IBA
11/2021 - 05/2015
2EnzymesIBA
01/2020 - 01/2018
2Biomarkers (Surrogate Marker)IBA
06/2004 - 01/2004
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022
1SodiumIBA
11/2021
1Dicarboxylic Acid TransportersIBA
11/2021
1Urea (Carbamide)FDA LinkGeneric
03/2021
1NitrogenIBA
03/2021
1Fibrinogen (Factor I)FDA Link
01/2021
1Ferritins (Ferritin)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1AntibodiesIBA
10/2020
1locked nucleic acidIBA
01/2020
1erucylphosphocholineIBA
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020
1LigandsIBA
01/2020
1Antisense OligonucleotidesIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2018
1AcetyltransferasesIBA
01/2018
1peptide AIBA
06/2014
1ChemokinesIBA
06/2014
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
08/2012
1N-Methylaspartate (NMDA)IBA
01/2012
1Glutamate Receptors (Glutamate Receptor)IBA
01/2012
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2012
1Proteins (Proteins, Gene)FDA Link
01/2012
1NestinIBA
08/2011
1Glial Fibrillary Acidic ProteinIBA
08/2011
1VimentinIBA
08/2011

Therapy/Procedure

3Therapeutics
01/2021 - 06/2014
2Lasers (Laser)
06/2004 - 01/2004